Quarterly report pursuant to Section 13 or 15(d)

Consolidated Condensed Statements of Cash Flows (Unaudited)

v3.22.1
Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
CASH FLOWS FROM OPERATING ACTIVITIES    
Net income (loss) $ (12,958,589) $ 83,356,742
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Depreciation and amortization 18,538,926 1,298,936
Impairment of patents 919,363
Deferred tax benefit (4,297,064)
Change in fair value of warrant liability 1,591,895
Change in fair value of investment securities 5,541,642 (131,822,950)
Impairment of digital currencies 19,551,254 662,199
Stock based compensation 9,275,352 51,031,595
Amortization of right-of-use assets 26,132 16,597
Amortization of bond issuance costs 970,886
Other adjustments from operations 80,863
Changes in operating assets and liabilities:    
Digital currencies (51,868,867) (9,152,816)
Deposits (6,287,068)
Lease liability (16,704) (18,701)
Prepaid expenses and other assets (6,210,505) (113,847)
Accounts payable and accrued expenses (1,087,007) (13,774)
Accrued interest 1,843,151
Net cash used in operating activities (26,059,098) (3,083,261)
CASH FLOWS FROM INVESTING ACTIVITIES    
Advances to vendor (192,390,625) (63,221,724)
Purchase of property and equipment (6,534,120) (25,456,714)
Purchase of equity investments (10,499,825)
Purchase of investment securities (150,000,000)
Sale of digital currencies 16,000
Net cash used in investing activities (209,424,570) (238,662,438)
CASH FLOWS FROM FINANCING ACTIVITIES    
Proceeds from issuance of common stock/At-the-market offering 88,127,270 327,103,650
Offering costs for the issuance of common stock/At-the-market offering (2,654,290) (14,906,805)
Proceeds received on exercise of options and warrants 160,164
Net cash provided by financing activities 85,472,980 312,357,009
Net (decrease) increase in cash and cash equivalents (150,010,688) 70,611,310
Cash and cash equivalents — beginning of period 268,522,019 141,322,776
Cash and cash equivalents — end of period 118,511,331 211,934,086
Supplemental schedule of non-cash investing and financing activities:    
Options exercised into common stock 2
Operating lease assets obtained in exchange for new operating lease liabilities 1,352,623
Receivable due to share issuance 4,720,197
Common stock issued for service and license agreements $ 4,579,999